Tharimmune Inc - THAR Future Profit

THAR (Tharimmune Inc) - company brandmark

High cash burn prior to the launch of sales is putting pressure on Tharimmune, Inc. (THAR) quotes. However, the diversification of immunotherapy methods for oncology and dermatology reduces regulatory threats. The business's expected net profit confirms this trend, with the indicator holding around . Simultaneously, the company is implementing energy-efficient technologies and strict waste disposal controls to comply with ESG environmental standards.

THAR: tharimmune.com Future Profit 07/04/2022 - 11/17/2026

Tharimmune Corp - analytical breakdowns and key metrics (THAR)

- price and consensus price forecast:
Fundamental company analysis:Tharimmune, Inc.
Core merchandise of Tharimmune Inc

The indicator eliminates the time lag of quarterly reporting by converting discrete estimates into a continuous trajectory of expected earnings. By analyzing the organization's future profitability, the investor observes the capitalization dynamics of Tharimmune, Inc. (THAR) developments in skin and liver therapy. The metric measures the probability of monetizing targeted antibodies for the treatment of chronic pruritus. An overly smooth trend necessitates a forensic audit to check for artificial stability. This determines the actual investment reliability of the asset.

Direct competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit